VENICE Study Nevirapine Full Dose/Dose Escalation

NCT00704249 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

80

Enrollment

OTHER

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: nevirapine
DRUG: nevirapine

Sponsor

Clinical Trial Agency of HIV Study Group